Skip to content
Novonesis
-
Novonesis to invest US$704.8M in advanced enzyme production facility in India
The investment is designed to increase production capacity, support growing global demand for biosolutions and strengthen the resilience and flexibility of the company’s international supply network.
-
Novonesis to acquire remaining stake in MicroBioGen to strengthen global yeast capabilities
The deal builds on Novonesis’ original 2013 investment in MicroBioGen and its current 23% stake in the Sydney-based firm, extending a collaboration between the two companies that spans more than a decade.
-
Novonesis launches Optiva® LS Prime to help bakers cut sugar by up to 50%
According to Novonesis, Optiva® LS Prime works by converting starch into sugar during the baking process, allowing formulators and bakers to maintain the desired sweetness with significantly less added sugar